What is the recommended haloperidol dose for a 12‑year‑old female for acute nausea or vomiting?

Haloperidol Dosing for 12-Year-Old Female with Acute Nausea/Vomiting

For a 12-year-old female with acute nausea or vomiting, the recommended haloperidol dose is 0.5-2 mg PO/IM, which can be repeated every 2 hours as needed, with a maximum of 30 mg daily. 1

Pediatric Dosing Guidelines

According to the American Academy of Pediatrics guidelines for pediatric patients, haloperidol dosing for children (prepubertal ages 6-12 years) is structured as follows 1:

• Initial dose: 0.5-2 mg (child dose)
• Route: Oral (PO) or intramuscular (IM)
• Frequency: May repeat every 2 hours
• Maximum daily dose: 30 mg
• Alternative weight-based dosing: 0.05-0.1 mg/kg PO/IM/IV 1

Pharmacokinetics for Treatment Planning

The onset and duration of action vary by route 1:

• Oral (PO): Onset 20-30 minutes, Peak 45-60 minutes, Duration 6-8 hours
• Intramuscular (IM): Onset 10-20 minutes, Peak 20-30 minutes, Duration 4-8 hours

Critical Safety Considerations

Monitor closely for these adverse effects 1, 2, 3:

1. Extrapyramidal symptoms (EPS): Including acute dystonia, akathisia, and drug-induced Parkinsonism - more common in young patients
2. QTc prolongation: Haloperidol causes approximately 7 ms QTc prolongation 2
3. Hypotension and dystonic reactions: Can occur with repeated doses 4
4. Sedation: Expected effect but monitor respiratory status

Contraindications to avoid 3:

• Parkinson's Disease or Dementia with Lewy Bodies (absolute contraindication)
• Known hypersensitivity to haloperidol

Clinical Context for Nausea/Vomiting

While the AAP guidelines primarily address haloperidol for acute agitation 1, research evidence supports its antiemetic efficacy. A meta-analysis demonstrated that 0.5-4 mg haloperidol is effective for nausea/vomiting prophylaxis and treatment 5. However, pediatric-specific antiemetic data for haloperidol is limited - most studies focus on adult populations 5, 6, 7, 8, 9.

Practical Dosing Algorithm

Start with 0.5-1 mg for a 12-year-old female:

• Use the lower end (0.5 mg) if the patient is small for age or has no prior antipsychotic exposure
• Use 1-2 mg if symptoms are severe or the patient has adequate body mass
• Reassess at 2 hours; if inadequate response, repeat the dose
• Do not exceed 30 mg in 24 hours

Important Caveats

The evidence base has significant limitations:

• The AAP guidelines 1 focus on haloperidol for behavioral emergencies, not specifically nausea/vomiting
• Antiemetic research is predominantly in adults 5, 6, 7, 8, 9
• FDA labeling states "controlled trials to establish safety and effectiveness of intramuscular administration in children have not been conducted" 3

Consider alternative antiemetics first (ondansetron, metoclopramide) given the stronger pediatric evidence base for those agents, unless there are specific contraindications or prior treatment failures.

If using haloperidol, ensure:

• Baseline assessment excludes contraindications
• Monitoring for dystonic reactions (have diphenhydramine available)
• Avoid combining with other QTc-prolonging medications 2
• Consider ECG monitoring if using repeated doses or in patients with cardiac risk factors